50–60% of the patients that are diagnosed with LEMS also have present an associated tumor, which is typically small-cell lung carcinoma (SCLC).
O 50–60% dos pacientes que son diagnosticados desta síndrome tamén presentan un tumor asociado, que é tipicamente un carcinoma pulmonar de células pequenas (SCLC).